An Anesthesia-Free Pharmacological Assay for Zebrafish Heart Failure Models Using a Microfluidic Platform

Background: The zebrafish model is extensively utilized for phenotypic screening, particularly in heart failure research. However, traditional photography-based data collection requires tricaine methanesulfonate (MS-222) anesthesia, which can suppress cardiac function and introduce artifacts. This study presents a microfluidic platform designed to facilitate anesthesia-free, noninvasive in vivo photography of zebrafish heart failure models. Methods: Isoproterenol (ISO) induced heart failure in 1 day post-fertilization (dpf) zebrafish embryos. Larvae were assigned to three groups: Control (E3 embryo medium only), Model (1 mM ISO for 48 h from 1 dpf), and Positive (1 mM ISO + 10 μM propranolol for 48 h from 1 dpf). Subsequently, a microfluidic chip featuring tapered immobilization channels was adopted. The chip facilitated the photography and collection of cardiac function parameters from lateral and supine positions, including cardiac output (CO), blood flow velocity (BFV), ejection fraction (EF), stroke volume (SV), and fractional shortening (FS). All imaging was performed in completely independent parallel experiments, with no individual larva shared between the two imaging methods. Data obtained under hydrodynamic confinement were compared with those acquired under MS-222 anesthesia. Results: Cardiac parameters measured using the microfluidic platform were significantly higher than those under MS-222 anesthesia: CO (0.339 ± 0.032 vs. 0.279 ± 0.023 nL/s, p < 0.001), BFV (681 ± 53 vs. 604 ± 38 μm/s, p < 0.001), EF (10.3 ± 0.7% vs. 6.6 ± 0.7%, p < 0.001), SV (184,519 ± 12,822 vs. 97,979 ± 5306 μm3, p < 0.001), and FS (7.3 ± 1.8% vs. 3.7 ± 0.9%, p < 0.001). Strong correlations (R2 > 0.85, p < 0.0001) revealed that anesthesia underestimated parameters by 11.3–49.3%. Conclusions: Compared with the traditional anesthesia-based method, the microfluidic platform enables more precise cardiac parameter collection in a zebrafish heart failure model than when anesthesia is used, offering a reliable tool for phenotypic screening of zebrafish embryos.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2026-09-06
DOI
https://doi.org/10.3390/biomedicines14092005
Primary Topic
Zebrafish Biomedical Research Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

An Anesthesia-Free Pharmacological Assay for Zebrafish Heart Failure Models Using a Microfluidic Platform

Kuo Xu, Wenli Xie, Jinyan Zhao, Xianjun Fu et al.
Biomedicines
Zebrafish Biomedical Research Applications
article

An Anesthesia-Free Pharmacological Assay for Zebrafish Heart Failure Models Using a Microfluidic Platform

Kuo Xu, Wenli Xie, Jinyan Zhao, Xianjun Fu, Fangrui Liu, Qiuyue Song
article en

Abstract

Background: The zebrafish model is extensively utilized for phenotypic screening, particularly in heart failure research. However, traditional photography-based data collection requires tricaine methanesulfonate (MS-222) anesthesia, which can suppress cardiac function and introduce artifacts. This study presents a microfluidic platform designed to facilitate anesthesia-free, noninvasive in vivo photography of zebrafish heart failure models. Methods: Isoproterenol (ISO) induced heart failure in 1 day post-fertilization (dpf) zebrafish embryos. Larvae were assigned to three groups: Control (E3 embryo medium only), Model (1 mM ISO for 48 h from 1 dpf), and Positive (1 mM ISO + 10 μM propranolol for 48 h from 1 dpf). Subsequently, a microfluidic chip featuring tapered immobilization channels was adopted. The chip facilitated the photography and collection of cardiac function parameters from lateral and supine positions, including cardiac output (CO), blood flow velocity (BFV), ejection fraction (EF), stroke volume (SV), and fractional shortening (FS). All imaging was performed in completely independent parallel experiments, with no individual larva shared between the two imaging methods. Data obtained under hydrodynamic confinement were compared with those acquired under MS-222 anesthesia. Results: Cardiac parameters measured using the microfluidic platform were significantly higher than those under MS-222 anesthesia: CO (0.339 ± 0.032 vs. 0.279 ± 0.023 nL/s, p < 0.001), BFV (681 ± 53 vs. 604 ± 38 μm/s, p < 0.001), EF (10.3 ± 0.7% vs. 6.6 ± 0.7%, p < 0.001), SV (184,519 ± 12,822 vs. 97,979 ± 5306 μm3, p < 0.001), and FS (7.3 ± 1.8% vs. 3.7 ± 0.9%, p < 0.001). Strong correlations (R2 > 0.85, p < 0.0001) revealed that anesthesia underestimated parameters by 11.3–49.3%. Conclusions: Compared with the traditional anesthesia-based method, the microfluidic platform enables more precise cardiac parameter collection in a zebrafish heart failure model than when anesthesia is used, offering a reliable tool for phenotypic screening of zebrafish embryos.

BiomedicinesVol. 14(9)
Shandong University of Traditional Chinese Medicine (CN)
Openalex Percentile: Top 14%
Zebrafish Biomedical Research Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.